|
Patients' and physicians' risk-benefit trade-off preferences for metastatic colorectacl cancer treatments. |
|
|
Consulting or Advisory Role - Genentech |
Research Funding - Genentech |
|
|
|
Consulting or Advisory Role - Genentech |
|
|
|
Stock and Other Ownership Interests - Roche Pharma AG |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Genentech |
Research Funding - Genentech |
|
|
Consulting or Advisory Role - Amgen (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Sanofi (Inst) |
Research Funding - Bayer (Inst); Boston Biomedical (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst); Sanofi (Inst) |
Travel, Accommodations, Expenses - Amgen; Bayer; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche |